Browsing by Author Giannakakis, T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 10 of 10
TitleAuthor(s)Issue date???itemlist.???
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyFountzilas, G.; Polichronis, A.; Katsohis, K.; Gennatas, K.; Toussis, D.; Skarlos, D.; Kosmidis, P.; Vassilaros, S.; Semoglou, C.; Giannakakis, T.; Fahantidis, E.; Klouvas, G.; Tsavaris, N.; Konstantaras, C.; Makrantonakis, P.; Kolotas, C.; Zamboglou, N.; Tsiliakos, S.; Hainoglou, D.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group StudyNicolaides, C.; Fountzilas, G.; Zoumbos, N.; Skarlos, D.; Kosmidis, P.; Pectasides, D.; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, N.24-Nov-2015-
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group studyFountzilas, G.; Skarlos, D.; Katsohis, C.; Pavlidis, N.; Giannakakis, T.; Bafaloukos, D.; Fahantidis, E.; Klouvas, G.; Beer, M.; Kosmidis, P.24-Nov-2015-
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group studyFountzilas, G.; Skarlos, D.; Pavlidis, N. A.; Makrantonakis, P.; Tsavaris, N.; Kalogera-Fountzila, A.; Giannakakis, T.; Beer, M.; Kosmidis, P.24-Nov-2015-
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancerFountzilas, G.; Skarlos, D.; Giannakakis, T.; Athanasiadis, A.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, C.; Pavlidis, N.; Kosmidis, P.24-Nov-2015-
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G.24-Nov-2015-
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group studyJaninis, J.; Giannakakis, T.; Athanasiadis, A.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Nikolaides, K.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group studyFountzilas, G.; Athanassiades, A.; Giannakakis, T.; Briasoulis, E.; Bafaloukos, D.; Kalogera-Fountzila, A.; Onienaoum, A.; Kalofonos, H.; Pectasides, D.; Andreopoulou, E.; Bamia, C.; Kosmidis, P.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanomaBafaloukos, D.; Pavlidis, N.; Fountzilas, G.; Skarlos, D.; Klouvas, G.; Makrantonakis, P.; Giannakakis, T.; Tsavaris, N.; Kosmidis, P.24-Nov-2015-
Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicinNicolaides, C.; Giannakakis, T.; Skarlos, D.; Athanassiadis, A.; Fountzilas, G.; Damigos, D.; Pavlidis, N.24-Nov-2015-